Urgent Health Alert: Mosquito-Borne Illness Spreading, Travel Warnings Issued
Federal health authorities have sounded the alarm with a new urgent travel warning concerning a highly contagious mosquito-borne illness that is currently circulating in the Americas. The Centers for Disease Control and Prevention (CDC) has issued a Level 2 travel advisory for Bolivia, strongly advising American travellers to the South American nation to “practice enhanced precautions.”
This advisory comes in response to the concerning resurgence of chikungunya, a mosquito-borne virus that has seen a worrying uptick in cases across Africa, the Americas, Asia, Europe, the Caribbean, and the Indian and Pacific Oceans. In Bolivia alone, the year 2025 saw approximately 5,000 reported cases of chikungunya, tragically resulting in four deaths. Experts anticipate that these numbers are likely to continue their upward trend into 2026.
The warning for Bolivia follows closely on the heels of similar Level 2 advisories issued for Seychelles, an island nation in the Indian Ocean, and Suriname, a small country situated on the northeastern coast of South America. These advisories underscore the growing global concern surrounding the spread of this debilitating virus.
Understanding Chikungunya: Symptoms and Transmission
Chikungunya is transmitted through the bite of infected Aedes mosquitoes, the same species responsible for spreading dengue and Zika viruses. Once infected, individuals can experience a range of debilitating symptoms, typically appearing three to seven days after a mosquito bite.
- Key Symptoms of Chikungunya:
- High fever
- Severe joint pain, often described as debilitating
- Headaches
- Muscle aches
- Swelling, particularly around the joints
- Skin rashes
While most acute symptoms usually subside within a week, a significant proportion of those infected go on to develop persistent and excruciating arthritis. This chronic condition can linger for months, or in some unfortunate cases, even years, severely impacting quality of life.
Who is Most at Risk?
The CDC has specifically identified certain demographics as facing a considerably higher risk of developing severe complications from chikungunya. These include:
- Older adults: Individuals aged 65 and above are more susceptible to severe outcomes.
- Individuals with underlying medical conditions: Those with pre-existing health issues such as hypertension or heart disease are at increased risk.
- Newborns and pregnant individuals: This group is critically vulnerable. Pregnant travellers, especially those nearing their due date, are strongly urged to reconsider travel to affected areas altogether. This is due to the risk of mothers transmitting the virus to their babies before or during delivery.
Prevention is Key: How to Protect Yourself
Travellers heading to regions where chikungunya is prevalent are strongly advised to take proactive measures to prevent both contracting and spreading the virus. The CDC recommends the following precautions:
- Insect Repellent: Use effective insect repellents containing DEET, picaridin, or oil of lemon eucalyptus on exposed skin.
- Protective Clothing: Wear long-sleeved shirts and long pants to minimise exposed skin.
- Secure Accommodations: Stay in accommodations that are air-conditioned or have screens on windows and doors to prevent mosquitoes from entering.
- Vaccination: For travellers visiting areas with a known chikungunya outbreak, vaccination is recommended. A single-dose shot is approved in the United States for individuals aged 12 and older.
Global Outbreaks and Local Concerns
The current warnings are part of a broader global concern about chikungunya. Last year, a significant outbreak began in China, which was believed to be the country’s largest to date, with over 16,000 cases reported. This led to a CDC Level 2 travel advisory for the nation, urging Americans to exercise extra caution. Similar advisories have since been issued for Kenya, Cuba, Madagascar, Somalia, and Sri Lanka.
While deaths due to chikungunya in the United States are extremely rare – occurring in less than one in 1,000 cases – the majority of reported instances involve travellers returning from or visiting areas with active outbreaks. However, there have been rare instances of locally acquired cases, where infected mosquitoes have transmitted the virus within the US. These have been documented in Florida (2014), Texas (2015), and most recently, New York in 2025.
In 2025, Florida health officials confirmed over 320 cases linked to international travel, in addition to one case of locally acquired disease. The very first confirmed locally acquired case in the US was reported in June 2016 in a Cameron County resident who fell ill in November 2015 without having travelled abroad. More recently, in September 2025, New York health officials reported a suspected case in a 60-year-old woman on Long Island. Despite not travelling off the island, lab tests later confirmed she had contracted the virus locally, marking the first such case ever recorded in the New York City area. Three other individuals in New York tested positive for chikungunya in 2025 after returning from countries where the virus is known to circulate.
Federal health officials also issued a similar travel warning in early December 2025 for Sri Lanka and another in August for Guangdong Province, China.
The Long-Term Impact of Chikungunya
Globally, the virus has had a significant impact, with hundreds of thousands of infections and hundreds of deaths attributed to it annually. For a substantial number of patients, around 40%, the severe joint pain associated with chikungunya evolves into a chronic, rheumatoid arthritis-like condition. This can persist for months, years, or even result in lifelong disability.
The intensity of this joint pain can be so severe that it forces patients into stooped or contorted postures, making basic tasks like walking incredibly difficult. The pain commonly affects both sides of the body, typically targeting the hands, wrists, ankles, and knees. This persistent inflammation can lead to joint stiffness, swelling, and visible erosion on X-rays, profoundly impacting a person’s mobility, ability to work, and overall quality of life.
In rarer instances, severe chikungunya can affect the nervous system, leading to serious conditions such as encephalitis (brain inflammation), meningitis, seizures, and Guillain-Barré syndrome, a severe autoimmune disorder where the body’s immune system mistakenly attacks its own peripheral nerves.
